Jonathan Lippy
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Protein Kinase Regulation and GTPase Signaling, Myeloproliferative Neoplasms: Diagnosis and Treatment, Peroxisome Proliferator-Activated Receptors, Pain Mechanisms and Treatments
Most-Cited Works
- → Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily(2009)275 cited
- → Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities(2008)122 cited
- → Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain(2016)119 cited
- → Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core(2015)116 cited
- → Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening(2010)80 cited
- → Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors(2016)69 cited